A world-leading dermatology research group that pioneers world-class skin cancer care by advancing immune-based therapies through cutting-edge translational research.
The team has established its self as a world-class skin cancer centre providing the best clinical care connected to translation and clinical research. We intensively investigate the immune biology of cutaneous lymphomas, cutaneous melanoma and epithelial skin cancers. Based on the microenvironment of these tumours, we have established immune interventions in cell cultures and animal models. Translational research applies this new knowledge to our patients in order to provide effective treatment with best quality of life.